2024-11-0920191553-838910.1016/j.carrev.2018.11.0082-s2.0-85057377582http://dx.doi.org/10.1016/j.carrev.2018.11.008https://hdl.handle.net/20.500.14288/7679MitraClip is an effective treatment method for severe mitral regurgitation in high-risk populations in terms of reducing morbidity and frequency of hospitalizations. Efficacy and safety of MitraClip device in elderly population have been established, yet there are only 2 case reports of MitraClip implantation in the younger patients, who generally tend to have less surgical risk (Gorenflo et al.; Joffe et al., 2016). Wedescribe a 19-year-old patient with severe mitral regurgitation with prior mitral valve annuloplasty and received MitraClip implantation due to high-surgical risk.Cardiac and cardiovascular systemsReview1878-0938513937600021Q34181